Radiother Oncol. 2017 Aug;124(2):232-239. doi: 10.1016/j.radonc.2017.06.026. Epub 2017 Jul 18.
To determine dosimetric parameters associated with osteoradionecrosis (ORN) in oropharyngeal cancer (OPC) patients in the IMRT era.
Subsequent to institutional review board approval, we identified ORN in OPC patients treated with IMRT from 2002 to 2013. 1:2 case-control matching was implemented. Mandibular dose-volume histograms (DVH) were extracted. Dosimetric parameters were compared using non-parametric stats. Recursive partitioning analysis (RPA) was done to identify DVH correlates of ORN.
68 ORN cases and 131 controls were matched. Median follow-up was 41months and median time to development of ORN was 16months. Mandibular mean dose was significantly higher in the ORN cohort (48.1 vs 43.6Gy, p<0.0001). However, the maximum dose was not statistically different. DVH bins from V35 to V73 were all significantly higher in the ORN cohort compared with controls (p<0.0006). Two DVH parameters were identified in RPA analysis, V43 and V58. The majority (81%) of ORN cases were observed with both V44≥42% and V58≥25%.
Our data demonstrate that a wide range of DVH parameters in the intermediate and high beam path were all significantly higher in ORN patients. Mandibular V44<42% and V58<25% represent reasonable DVH constraints for IMRT plan acceptability, when tumor coverage is not compromised.
确定调强放射治疗(IMRT)时代口咽癌(OPC)患者中与放射性骨坏死(ORN)相关的剂量学参数。
经机构审查委员会批准后,我们确定了2002年至2013年接受IMRT治疗的OPC患者中的ORN病例。实施了1:2病例对照匹配。提取下颌骨剂量体积直方图(DVH)。使用非参数统计比较剂量学参数。进行递归划分分析(RPA)以确定ORN的DVH相关因素。
匹配了68例ORN病例和131例对照。中位随访时间为41个月,ORN发生的中位时间为16个月。ORN队列中的下颌骨平均剂量显著更高(48.1对43.6Gy,p<0.0001)。然而,最大剂量在统计学上无差异。与对照组相比,ORN队列中从V35到V73的DVH区间均显著更高(p<0.0006)。在RPA分析中确定了两个DVH参数,即V43和V58。大多数(81%)ORN病例在V44≥42%且V58≥25%时被观察到。
我们的数据表明,ORN患者中中高射线路径的多种DVH参数均显著更高。当下颌骨V44<42%且V58<25%时,在不影响肿瘤覆盖的情况下,代表了IMRT计划可接受性的合理DVH限制。